Systemic immune responses induced by mucosal administration of lipopeptides without adjuvant

European Journal of Immunology

Volumn 32, Issue 8, 2002, Pages 2274-2281

  BenMohamed, Lbachir ^a,d   Belkaid, Yasmine ^b   Loing, Estelle ^c   Brahimi, Karima ^a   Gras Masse, Helene ^c   Druilhe, Pierre ^a  

^a INSTITUT PASTEUR   (France)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c INSTITUT PASTEUR DE LILLE   (France)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Dendritic cell; Lipopeptide; Macrophage; Mucosal immunization; Systemic B and T cell responses

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 4; LIPOPEPTIDE; VACCINE;

ALLERGY; ANIMAL CELL; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CYTOKINE PRODUCTION; DENDRITIC CELL; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOCOMPETENT CELL; INFECTION; INGUINAL LYMPH NODE; MACROPHAGE; MOUSE; MOUTH MUCOSA; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE; TH1 CELL;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ADMINISTRATION, SUBLINGUAL; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, PROTOZOAN; DENDRITIC CELLS; IMMUNIZATION; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; T-LYMPHOCYTES; TH1 CELLS;

EID: 0036687165     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200208)32:8<2274::AID-IMMU2274>3.0.CO;2-C     Document Type: Article

References (24)

1. Optimism over vaccines administered via mucosal surfaces
2. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity
3. Intranasal immunization is superior to vaginal, gastric, or rectal immunization for the induction of systemic and mucosal anti-HIV antibody responses
4. Lipopeptide immunization without adjuvant induces potent and longlasting B, T helper; and cytotoxic T lymphocytes responses against a malaria liver stage antigen in mice and chimpanzees
5. High immunogenicity in chimpanzees of peptides and lipopeptides derived from four new Plasmodium falciparum pre-erythrocytic molecules
6. The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection
7. Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3
8. Lipopeptides induce cell-mediated anti-HIV immune responses in seronegative volunteers
9. Extension of HLA-A*0201-restricted minimal epitope by N epsilon-palmitoyl-lysine increases the life span of functional presentation to cytotoxic T cells
10. + T lymphocyte activation
11. The Plasmodium falciparum liver-stage-antigen LSA-1 is well conserved and contains potent B- and T cell determinants
12. Dendritic cells and the control of immunity
13. Antigen presentation in the murine oral epithelium
14. Unsafe injections
15. Effectiveness of liposomes possessing surface-linked recombinant B subunit of cholera toxin as an oral antigen delivery system
16. Proteosomes, emulsomes, and cholera toxin B improve nasal immunogenicity of human immunodeficiency virus gp160 in mice: Induction of serum, intestinal, vaginal, and lung IgA and IgG
17. Immunopotentiating of mucosal and systemic antibody responses in mice by intranasal immunization with HLT-combined influenza virosoma vaccine
18. Oral vaccination with immune stimulating complexes
19. Oral administration of an antigenic synthetic lipopeptide (MAP-P3C) evokes salivary antibodies and systemic humoral and cellular responses
20. Interaction of mitogenic bacterial lipoprotein and a synthetic analogue with mouse lymphocytes. Isolation and characterization of binding proteins
21. Intranasal immunization with plasmid DNA-lipid complexes elicits mucosal immunity in the female genital and rectal tracts
22. Improved detection of human antibodies to a Plasmodium antigen using a peptide modified with Aib residues
23. A novel Plasmodium falciparum sporozoite and liver stage antigen (SALSA) defines major B, T helper, and CTL epitopes
24. Induction of CTL response by a minimal epitope vaccine in HLA A*0201/DR1 transgenic mice: Dependence on HLA class II restricted Th response